Claritas Pharmaceuticals's total assets for Q3 2021 were $11.02M, a decrease of -1.17% from the previous quarter. CLAZF total liabilities were $7.74M for the fiscal quarter, a -7.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.